GSE177075
The ISR activation confers vulnerability to mitoribosome-targeting antibiotics in melanoma
We report the changes in translatome of a commercially available melanoma line upon acquisition of therapy resistance Overall design: The ribosome-bound RNAs of a melanoma line in control condition or upon activation of the ISR were compared